SMTL ID : 5kcv.1

Crystal structure of allosteric inhibitor, ARQ 092, in complex with autoinhibited form of AKT1

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x 6S1: 3-[3-[4-(1-azanylcyclobutyl)phenyl]-5-phenyl-imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine(Non-covalent)

6S1.1: 16 residues within 4Å: Chain A: N.67, N.68, Q.93, W.94, T.96, L.224, T.225, L.278, V.284, V.285, Y.286, R.287, D.288, I.304, T.305, D.306 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:N.67, A:Q.93, A:Q.93, A:W.94, A:W.94, A:T.96, A:L.224, A:L.278, A:V.284, A:V.284, A:I.304 Hydrogen bonds: A:T.225, A:T.225, A:D.288 Water bridges: A:Y.286 pi-Stacking: A:W.94

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lapierre, J.M. et al., Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor. J.Med.Chem. (2016)

Release Date

2016-06-29

Peptides

RAC-alpha serine/threonine-protein kinase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

RAC-alpha serine/threonine-protein kinase